Healthcare
Oracle and AstraZeneca Partner on AI-Enabled Healthcare Innovation
Oracle and AstraZeneca will explore AI-enabled patient recruitment and evidence generation, beginning with hypertension research in Abu Dhabi in partnership with M42.
Oracle and AstraZeneca announced a non-binding agreement to explore AI and real-world data for identifying patients eligible for clinical trials. The companies plan to combine AstraZeneca’s therapeutic expertise with Oracle’s health-data, cloud, AI, analytics, and clinical-workflow capabilities. The initial work includes hypertension research in Abu Dhabi with M42. The project matters because faster patient identification could improve trial recruitment and expand access to clinical research.
Original source: Oracle